Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

(2015) Angelo Gámez-Pozo et al.   NEOPLASIA

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity

(2011) J. Bellmunt et al.   ANNALS OF ONCOLOGY

Molecular Classification of Adult Renal Epithelial Neoplasms Using MicroRNA Expression and Virtual Karyotyping

(2011) Martin P. Powers et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature

(2011) Youssef M. Youssef et al.   EUROPEAN UROLOGY

HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer

(2011) Colin F. Spraggs et al.   JOURNAL OF CLINICAL ONCOLOGY

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

(2011) Jesus Garcia-Donas et al.   LANCET ONCOLOGY

Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma

(2011) Liang Zhou et al.   PLoS One

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

(2011) Joana Heinzelmann et al.   WORLD JOURNAL OF UROLOGY

PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis

(2010) R. Catena et al.   CANCER RESEARCH

Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma

(2010) J. Lin et al.   CARCINOGENESIS

Selection of extreme phenotypes: the role of clinical observation in translational research

(2010) José Luis Pérez-Gracia et al.   Clinical & Translational Oncology

The miR-200 family controls  -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

(2010) S. Leskela et al.   ENDOCRINE-RELATED CANCER

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

(2010) James N. Ingle et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

(2010) Ondrej Slaby et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

(2009) J L Perez-Gracia et al.   BRITISH JOURNAL OF CANCER

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

(2009) Junfang Ji et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9

(2008) Loredana Moro et al.   CANCER SCIENCE

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH